Armistice Capital’s HeartSciences Inc Warrant HSCSW Stock Holding History

Armistice Capital’s Portfolio HSCSW Stock Details HSCSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,529	Closed	-$106	–	257
2024 Q4	$106	Buy	+3,529	New	+$133	﹤0.01%	226
2024 Q2	–	Sell	-352,941	Closed	-$17.6K	–	315
2024 Q1	$17.6K	Hold	352,941	–	–	﹤0.01%	321
2023 Q4	$17.6K	Hold	352,941	–	–	﹤0.01%	275
2023 Q3	$17.6K	Hold	352,941	–	–	﹤0.01%	241
2023 Q2	$55.4K	Sell	352,941 -1	-0%	–	﹤0.01%	197
2023 Q1	$77.4K	Buy	352,942 +1	+0%	–	﹤0.01%	197
2022 Q4	$101K	Hold	352,941	–	–	﹤0.01%	163
2022 Q3	$109K	Hold	352,941	–	–	﹤0.01%	175
2022 Q2	$176	Buy	+352,941	New	+$163K	﹤0.01%	157

Other funds holding HSCSW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Armistice Capital's HSCSW Position: Q1 2025 in Review

Armistice Capital sold out of HeartSciences Inc Warrant (HSCSW) in Q1 2025, closing a stake of 3,529 shares — an estimated $106 sold.

Armistice Capital first reported a position in HSCSW in Q2 2022 and held it in 9 quarters. The position peaked at $109K in Q3 2022. 3 funds tracked by Wall St. Rank hold HSCSW as of Q1 2025.

Armistice Capital reported no remaining HeartSciences Inc Warrant position as of Q1 2025 after selling out during the quarter.
Armistice Capital sold 3,529 HeartSciences Inc Warrant shares in Q1 2025, an estimated $106.
Armistice Capital first reported a position in HeartSciences Inc Warrant in Q2 2022 and held it in 9 quarters.
Armistice Capital's HeartSciences Inc Warrant position peaked at $109K in Q3 2022.
3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.